FDA Warns On Atossa Genetics, Inc.'s Aspirate Test For Breast Cancer

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Nipple aspirate tests shouldn’t be used to replace mammograms or other tests for breast cancer, the FDA warns. The FDA cautioned women last week not to use nipple aspirate tests as a replacement for mammograms or other tests for breast cancer. The federal watchdog agency said the aspirate tests, which draw fluid from the breast through the nipple, “an determine whether the fluid collected from the breast contains any abnormal cells.”

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC